Beta Drugs Live BSE/NSE | Beta Drugs Fundamenta data | Beta Drugs Balance sheet | Beta Drugs Quarterly Results | Beta Drugs Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

121.13
17.06
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17.18
%
2.15

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales - 65.32 58.05 50.57 41.65 26.38 0.26 1.38 3.13 Net Sales Growth - 12.52% 14.79% 21.42% 57.88% 10046.15% -81.16% -55.91% Cost Of Goods Sold - 34.81 30.45 27.18 23.78 15.13 0.15 0.86 2.47 Gross Profit - 30.51 27.60 23.38 17.87 11.25 0.12 0.53 0.66 GP Margin - 46.71% 47.55% 46.23% 42.91% 42.65% 46.15% 38.41% 21.09% Total Expenditure - 53.57 47.74 41.11 34.37 23.36 0.26 1.19 2.88 Power & Fuel Cost - 1.23 0.80 0.76 0.66 0.00 0.00 0.00 0.00 % Of Sales - 1.88% 1.38% 1.50% 1.58% 0% 0% 0% 0% Employee Cost - 3.70 2.45 1.26 3.87 3.17 0.09 0.16 0.17 % Of Sales - 5.66% 4.22% 2.49% 9.29% 12.02% 34.62% 11.59% 5.43% Manufacturing Exp. - 6.50 6.50 5.46 0.60 0.00 0.00 0.00 0.00 % Of Sales - 9.95% 11.20% 10.80% 1.44% 0% 0% 0% 0% General & Admin Exp. - 5.74 5.38 3.75 2.74 5.06 0.02 0.18 0.24 % Of Sales - 8.79% 9.27% 7.42% 6.58% 19.18% 7.69% 13.04% 7.67% Selling & Distn. Exp. - 1.28 1.40 1.59 1.97 0.00 0.00 0.00 0.00 % Of Sales - 1.96% 2.41% 3.14% 4.73% 0% 0% 0% 0% Miscellaneous Exp. - 0.30 0.77 1.11 0.75 0.00 0.00 0.00 0.00 % Of Sales - 0.46% 1.33% 2.19% 1.80% 0% 0% 0% 0% EBITDA - 11.75 10.31 9.46 7.28 3.02 0.00 0.19 0.25 EBITDA Margin - 17.99% 17.76% 18.71% 17.48% 11.45% 0% 13.77% 7.99% Other Income - 0.42 0.32 0.24 0.03 0.02 0.00 0.00 0.00 Interest - 0.64 0.73 1.01 0.82 0.66 0.02 0.09 0.11 Depreciation - 2.58 2.42 1.85 1.24 1.24 0.10 0.08 0.10 PBT - 8.95 7.47 6.84 5.25 1.13 -0.11 0.02 0.04 Tax - 1.85 -0.25 0.07 0.98 0.00 0.00 0.00 0.00 Tax Rate - 20.67% -3.35% 1.02% 18.67% 0.00% 0.00% 0.00% 0.00% PAT - 7.10 7.71 6.76 4.27 1.13 -0.11 0.02 0.04 PAT before Minority Interest - 7.10 7.71 6.76 4.27 1.13 -0.11 0.02 0.04 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 10.87% 13.28% 13.37% 10.25% 4.28% -42.31% 1.45% 1.28% PAT Growth - -7.91% 14.05% 58.31% 277.88% 1127.27% -650.0% -50.0% Unadjusted EPS - 7.40 8.03 7.04 4.45 1.18 -0.11 0.02 0.04

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Net Sales

65.32

58.05

50.57

41.65

26.38

0.26

1.38

3.13

Net Sales Growth

12.52%

14.79%

21.42%

57.88%

10046.15%

-81.16%

-55.91%

Cost Of Goods Sold

34.81

30.45

27.18

23.78

15.13

0.15

0.86

2.47

Gross Profit

30.51

27.60

23.38

17.87

11.25

0.12

0.53

0.66

GP Margin

46.71%

47.55%

46.23%

42.91%

42.65%

46.15%

38.41%

21.09%

Total Expenditure

53.57

47.74

41.11

34.37

23.36

0.26

1.19

2.88

Power & Fuel Cost

1.23

0.80

0.76

0.66

0.00

% Of Sales

1.88%

1.38%

1.50%

1.58%

Employee Cost

3.70

2.45

1.26

3.87

3.17

0.09

0.16

0.17

% Of Sales

5.66%

4.22%

2.49%

9.29%

12.02%

34.62%

11.59%

5.43%

Manufacturing Exp.

6.50

5.46

0.60

0.00

% Of Sales

9.95%

11.20%

10.80%

1.44%

General & Admin Exp.

5.74

5.38

3.75

2.74

5.06

0.02

0.18

0.24

% Of Sales

8.79%

9.27%

7.42%

6.58%

19.18%

7.69%

13.04%

7.67%

Selling & Distn. Exp.

1.28

1.40

1.59

1.97

0.00

% Of Sales

1.96%

2.41%

3.14%

4.73%

Miscellaneous Exp.

0.30

0.77

1.11

0.75

0.00

% Of Sales

0.46%

1.33%

2.19%

1.80%

EBITDA

11.75

10.31

9.46

7.28

3.02

0.00

0.19

0.25

EBITDA Margin

17.99%

17.76%

18.71%

17.48%

11.45%

13.77%

7.99%

Other Income

0.42

0.32

0.24

0.03

0.02

0.00

Interest

0.64

0.73

1.01

0.82

0.66

0.02

0.09

0.11

Depreciation

2.58

2.42

1.85

1.24

0.10

0.08

0.10

PBT

8.95

7.47

6.84

5.25

1.13

-0.11

0.02

0.04

Tax

1.85

-0.25

0.07

0.98

0.00

Tax Rate

20.67%

-3.35%

1.02%

18.67%

0.00%

PAT

7.10

7.71

6.76

4.27

1.13

-0.11

0.02

0.04

PAT before Minority Interest

7.10

7.71

6.76

4.27

1.13

-0.11

0.02

0.04

Minority Interest

0.00

PAT Margin

10.87%

13.28%

13.37%

10.25%

4.28%

-42.31%

1.45%

1.28%

PAT Growth

-7.91%

14.05%

58.31%

277.88%

1127.27%

-650.0%

-50.0%

Unadjusted EPS

7.40

8.03

7.04

4.45

1.18

-0.11

0.02

0.04

Description TTM Mar 20 Mar 19 Mar 18
Net Sales - 90.81 65.93 50.57 Net Sales Growth - 37.74% 30.37% Cost Of Goods Sold - 44.36 33.43 27.18 Gross Profit - 46.45 32.50 23.38 GP Margin - 51.15% 49.29% 46.23% Total Expenditure - 72.90 54.12 41.11 Power & Fuel Cost - 1.67 0.95 0.76 % Of Sales - 1.84% 1.44% 1.50% Employee Cost - 6.95 3.80 1.26 % Of Sales - 7.65% 5.76% 2.49% Manufacturing Exp. - 8.33 6.93 5.46 % Of Sales - 9.17% 10.51% 10.80% General & Admin Exp. - 8.80 6.30 3.75 % Of Sales - 9.69% 9.56% 7.42% Selling & Distn. Exp. - 2.17 1.78 1.59 % Of Sales - 2.39% 2.70% 3.14% Miscellaneous Exp. - 0.64 0.93 1.11 % Of Sales - 0.70% 1.41% 2.19% EBITDA - 17.91 11.81 9.46 EBITDA Margin - 19.72% 17.91% 18.71% Other Income - 0.41 0.37 0.24 Interest - 2.59 1.43 1.01 Depreciation - 3.76 2.84 1.85 PBT - 11.97 7.91 6.84 Tax - 2.56 -0.13 0.07 Tax Rate - 21.39% -1.64% 1.02% PAT - 9.42 8.04 6.76 PAT before Minority Interest - 9.42 8.04 6.76 Minority Interest - 0.00 0.00 0.00 PAT Margin - 10.37% 12.19% 13.37% PAT Growth - 17.16% 18.93% Unadjusted EPS - 9.81 8.38 7.04

Description

TTM

Mar 20

Mar 19

Mar 18

Net Sales

90.81

65.93

50.57

Net Sales Growth

37.74%

30.37%

Cost Of Goods Sold

44.36

33.43

27.18

Gross Profit

46.45

32.50

23.38

GP Margin

51.15%

49.29%

46.23%

Total Expenditure

72.90

54.12

41.11

Power & Fuel Cost

1.67

0.95

0.76

% Of Sales

1.84%

1.44%

1.50%

Employee Cost

6.95

3.80

1.26

% Of Sales

7.65%

5.76%

2.49%

Manufacturing Exp.

8.33

6.93

5.46

% Of Sales

9.17%

10.51%

10.80%

General & Admin Exp.

8.80

6.30

3.75

% Of Sales

9.69%

9.56%

7.42%

Selling & Distn. Exp.

2.17

1.78

1.59

% Of Sales

2.39%

2.70%

3.14%

Miscellaneous Exp.

0.64

0.93

1.11

% Of Sales

0.70%

1.41%

2.19%

EBITDA

17.91

11.81

9.46

EBITDA Margin

19.72%

17.91%

18.71%

Other Income

0.41

0.37

0.24

Interest

2.59

1.43

1.01

Depreciation

3.76

2.84

1.85

PBT

11.97

7.91

6.84

Tax

2.56

-0.13

0.07

Tax Rate

21.39%

-1.64%

1.02%

PAT

9.42

8.04

6.76

PAT before Minority Interest

9.42

8.04

6.76

Minority Interest

0.00

PAT Margin

10.37%

12.19%

13.37%

PAT Growth

17.16%

18.93%

Unadjusted EPS

9.81

8.38

7.04

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 56.44 40.60 32.88 6.07 2.20 1.07 0.18 0.21 Share Capital 9.61 8.65 8.65 1.01 1.01 1.01 0.01 0.01 Total Reserves 46.83 31.95 24.23 5.06 1.19 0.06 0.17 0.15 Non-Current Liabilities 4.34 5.42 3.15 4.09 3.96 3.94 0.51 0.61 Secured Loans 3.45 4.89 2.34 1.40 1.53 1.57 0.17 0.25 Unsecured Loans 0.00 0.04 0.41 2.36 2.37 2.37 0.34 0.36 Long Term Provisions 0.56 0.33 0.00 0.00 0.06 0.00 0.00 0.00 Current Liabilities 22.59 19.49 13.55 13.05 9.04 3.00 0.67 0.95 Trade Payables 9.27 10.16 6.11 7.06 4.03 2.16 0.08 0.39 Other Current Liabilities 7.63 6.63 3.53 1.38 1.15 0.41 0.12 0.05 Short Term Borrowings 3.97 1.16 3.59 3.75 3.84 0.43 0.47 0.50 Short Term Provisions 1.72 1.54 0.33 0.86 0.03 0.00 0.00 0.00 Total Liabilities 83.37 65.51 49.58 23.21 15.20 8.01 1.36 1.77 Net Block 31.67 12.12 13.19 8.11 7.34 0.55 0.64 0.73 Gross Block 41.54 19.41 18.06 11.12 9.10 1.07 1.07 1.07 Accumulated Depreciation 9.87 7.29 4.87 3.02 1.76 0.52 0.42 0.34 Non Current Assets 45.05 33.17 17.26 8.11 7.40 6.32 0.66 0.74 Capital Work in Progress 0.08 14.69 1.35 0.00 0.00 5.71 0.00 0.00 Non Current Investment 6.12 1.61 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 7.18 4.74 2.72 0.00 0.07 0.07 0.01 0.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 38.32 32.34 32.32 15.11 7.80 1.69 0.70 1.03 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 6.10 6.41 2.80 2.40 2.86 1.28 0.29 0.47 Sundry Debtors 20.91 17.33 14.44 10.51 4.40 0.08 0.29 0.40 Cash & Bank 4.16 2.92 11.91 0.14 0.13 0.06 0.01 0.01 Other Current Assets 7.15 3.35 1.30 0.02 0.41 0.27 0.11 0.14 Short Term Loans & Adv. 3.43 2.34 1.87 2.03 0.39 0.24 0.09 0.12 Net Current Assets 15.73 12.85 18.78 2.06 -1.24 -1.31 0.03 0.08 Total Assets 83.37 65.51 49.58 23.22 15.20 8.01 1.36 1.77

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Shareholder's Funds

56.44

40.60

32.88

6.07

2.20

1.07

0.18

0.21

Share Capital

9.61

8.65

1.01

0.01

Total Reserves

46.83

31.95

24.23

5.06

1.19

0.06

0.17

0.15

Non-Current Liabilities

4.34

5.42

3.15

4.09

3.96

3.94

0.51

0.61

Secured Loans

3.45

4.89

2.34

1.40

1.53

1.57

0.17

0.25

Unsecured Loans

0.00

0.04

0.41

2.36

2.37

0.34

0.36

Long Term Provisions

0.56

0.33

0.00

0.06

0.00

Current Liabilities

22.59

19.49

13.55

13.05

9.04

3.00

0.67

0.95

Trade Payables

9.27

10.16

6.11

7.06

4.03

2.16

0.08

0.39

Other Current Liabilities

7.63

6.63

3.53

1.38

1.15

0.41

0.12

0.05

Short Term Borrowings

3.97

1.16

3.59

3.75

3.84

0.43

0.47

0.50

Short Term Provisions

1.72

1.54

0.33

0.86

0.03

0.00

Total Liabilities

83.37

65.51

49.58

23.21

15.20

8.01

1.36

1.77

Net Block

31.67

12.12

13.19

8.11

7.34

0.55

0.64

0.73

Gross Block

41.54

19.41

18.06

11.12

9.10

1.07

Accumulated Depreciation

9.87

7.29

4.87

3.02

1.76

0.52

0.42

0.34

Non Current Assets

45.05

33.17

17.26

8.11

7.40

6.32

0.66

0.74

Capital Work in Progress

0.08

14.69

1.35

0.00

5.71

0.00

Non Current Investment

6.12

1.61

0.00

Long Term Loans & Adv.

7.18

4.74

2.72

0.00

0.07

0.01

Other Non Current Assets

0.00

Current Assets

38.32

32.34

32.32

15.11

7.80

1.69

0.70

1.03

Current Investments

0.00

Inventories

6.10

6.41

2.80

2.40

2.86

1.28

0.29

0.47

Sundry Debtors

20.91

17.33

14.44

10.51

4.40

0.08

0.29

0.40

Cash & Bank

4.16

2.92

11.91

0.14

0.13

0.06

0.01

Other Current Assets

7.15

3.35

1.30

0.02

0.41

0.27

0.11

0.14

Short Term Loans & Adv.

3.43

2.34

1.87

2.03

0.39

0.24

0.09

0.12

Net Current Assets

15.73

12.85

18.78

2.06

-1.24

-1.31

0.03

0.08

Total Assets

83.37

65.51

49.58

23.22

15.20

8.01

1.36

1.77

Description Mar 20 Mar 19 Mar 18
Shareholder's Funds 57.11 40.92 32.88 Share Capital 9.61 8.65 8.65 Total Reserves 47.50 32.27 24.23 Non-Current Liabilities 13.21 9.07 3.15 Secured Loans 10.28 6.90 2.34 Unsecured Loans 0.00 0.04 0.41 Long Term Provisions 0.79 0.42 0.00 Current Liabilities 37.99 33.36 13.55 Trade Payables 14.49 13.12 6.11 Other Current Liabilities 11.35 7.68 3.53 Short Term Borrowings 9.65 10.88 3.59 Short Term Provisions 2.51 1.69 0.33 Total Liabilities 108.31 83.35 49.58 Net Block 43.82 17.67 13.19 Gross Block 58.29 25.38 18.06 Accumulated Depreciation 14.46 7.71 4.87 Non Current Assets 50.97 39.45 17.26 Capital Work in Progress 0.08 14.69 1.35 Non Current Investment 0.35 0.35 0.00 Long Term Loans & Adv. 5.60 5.62 2.72 Other Non Current Assets 1.12 1.12 0.00 Current Assets 57.34 43.91 32.32 Current Investments 0.00 0.00 0.00 Inventories 12.35 9.53 2.80 Sundry Debtors 31.93 25.03 14.44 Cash & Bank 5.39 3.30 11.91 Other Current Assets 7.69 3.51 1.30 Short Term Loans & Adv. 3.23 2.54 1.87 Net Current Assets 19.35 10.55 18.78 Total Assets 108.31 83.36 49.58

Description

Mar 20

Mar 19

Mar 18

Shareholder's Funds

57.11

40.92

32.88

Share Capital

9.61

8.65

Total Reserves

47.50

32.27

24.23

Non-Current Liabilities

13.21

9.07

3.15

Secured Loans

10.28

6.90

2.34

Unsecured Loans

0.00

0.04

0.41

Long Term Provisions

0.79

0.42

0.00

Current Liabilities

37.99

33.36

13.55

Trade Payables

14.49

13.12

6.11

Other Current Liabilities

11.35

7.68

3.53

Short Term Borrowings

9.65

10.88

3.59

Short Term Provisions

2.51

1.69

0.33

Total Liabilities

108.31

83.35

49.58

Net Block

43.82

17.67

13.19

Gross Block

58.29

25.38

18.06

Accumulated Depreciation

14.46

7.71

4.87

Non Current Assets

50.97

39.45

17.26

Capital Work in Progress

0.08

14.69

1.35

Non Current Investment

0.35

0.00

Long Term Loans & Adv.

5.60

5.62

2.72

Other Non Current Assets

1.12

0.00

Current Assets

57.34

43.91

32.32

Current Investments

0.00

Inventories

12.35

9.53

2.80

Sundry Debtors

31.93

25.03

14.44

Cash & Bank

5.39

3.30

11.91

Other Current Assets

7.69

3.51

1.30

Short Term Loans & Adv.

3.23

2.54

1.87

Net Current Assets

19.35

10.55

18.78

Total Assets

108.31

83.36

49.58

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 6.09 7.73 17.10 4.74 -0.37 1.39 0.21 0.00 PBT 8.95 7.47 6.84 5.25 1.13 -0.11 0.02 0.04 Adjustment 1.57 1.64 15.06 2.03 1.91 0.12 0.12 0.22 Changes in Working Capital -4.43 -1.38 -4.79 -2.54 -3.17 1.38 0.08 -0.26 Cash after chg. in Working capital 6.09 7.73 17.10 4.74 -0.12 1.39 0.21 0.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 -0.25 0.00 0.00 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -14.33 -16.08 -10.79 -2.00 -2.30 -5.71 0.00 -0.03 Net Fixed Assets -7.52 -14.69 -8.29 -2.02 -2.32 -5.71 0.00 Net Investments -4.51 -1.61 0.00 0.00 0.00 0.00 0.00 Others -2.30 0.22 -2.50 0.02 0.02 0.00 0.00 Cash from Financing Activity 9.48 -0.64 5.45 -2.72 2.75 4.37 -0.22 0.03 Net Cash Inflow / Outflow 1.24 -8.99 11.76 0.02 0.07 0.05 0.00 0.00 Opening Cash & Equivalents 0.00 0.00 0.14 0.13 0.06 0.01 0.01 0.01 Closing Cash & Equivalent 1.24 -8.99 11.91 0.14 0.13 0.06 0.01 0.01

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Cash From Operating Activity

6.09

7.73

17.10

4.74

-0.37

1.39

0.21

0.00

PBT

8.95

7.47

6.84

5.25

1.13

-0.11

0.02

0.04

Adjustment

1.57

1.64

15.06

2.03

1.91

0.12

0.22

Changes in Working Capital

-4.43

-1.38

-4.79

-2.54

-3.17

1.38

0.08

-0.26

Cash after chg. in Working capital

6.09

7.73

17.10

4.74

-0.12

1.39

0.21

0.01

Interest Paid

0.00

Tax Paid

0.00

-0.25

0.00

-0.01

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-14.33

-16.08

-10.79

-2.00

-2.30

-5.71

0.00

-0.03

Net Fixed Assets

-7.52

-14.69

-8.29

-2.02

-2.32

-5.71

0.00

Net Investments

-4.51

-1.61

0.00

Others

-2.30

0.22

-2.50

0.02

0.00

Cash from Financing Activity

9.48

-0.64

5.45

-2.72

2.75

4.37

-0.22

0.03

Net Cash Inflow / Outflow

1.24

-8.99

11.76

0.02

0.07

0.05

0.00

Opening Cash & Equivalents

0.00

0.14

0.13

0.06

0.01

Closing Cash & Equivalent

1.24

-8.99

11.91

0.14

0.13

0.06

0.01

Description Mar 20 Mar 19 Mar 18
Cash From Operating Activity 8.41 0.11 17.10 PBT 11.97 7.91 6.84 Adjustment 2.40 1.64 15.06 Changes in Working Capital -5.96 -9.43 -4.79 Cash after chg. in Working capital 8.41 0.11 17.10 Interest Paid 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -15.05 -20.78 -10.79 Net Fixed Assets -7.52 -14.69 Net Investments -4.51 -1.61 Others -3.02 -4.48 Cash from Financing Activity 8.73 12.07 5.45 Net Cash Inflow / Outflow 2.09 -8.61 11.76 Opening Cash & Equivalents 3.30 11.91 0.14 Closing Cash & Equivalent 5.39 3.30 11.91

Description

Mar 20

Mar 19

Mar 18

Cash From Operating Activity

8.41

0.11

17.10

PBT

11.97

7.91

6.84

Adjustment

2.40

1.64

15.06

Changes in Working Capital

-5.96

-9.43

-4.79

Cash after chg. in Working capital

8.41

0.11

17.10

Interest Paid

0.00

Tax Paid

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-15.05

-20.78

-10.79

Net Fixed Assets

-7.52

-14.69

Net Investments

-4.51

-1.61

Others

-3.02

-4.48

Cash from Financing Activity

8.73

12.07

5.45

Net Cash Inflow / Outflow

2.09

-8.61

11.76

Opening Cash & Equivalents

3.30

11.91

0.14

Closing Cash & Equivalent

5.39

3.30

11.91

Financial Ratios

Standalone /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 58.71 46.93 38.02 60.11 21.79 10.57 181.60 159.00 ROA 9.54% 13.41% 18.58% 22.23% 9.77% -2.44% 1.39% 2.48% ROE 14.63% 21.00% 34.73% 103.22% 69.39% -18.28% 12.74% 27.67% ROCE 16.85% 18.42% 28.63% 48.91% 21.92% -2.61% 8.64% 12.03% Fixed Asset Turnover 2.14 3.10 3.47 4.12 5.19 0.25 1.30 2.93 Receivable days 106.84 99.89 90.07 65.35 31.00 255.82 90.87 46.82 Inventory Days 34.95 28.97 18.77 23.03 28.61 1092.56 101.13 55.27 Payable days 68.45 65.88 61.70 62.26 57.45 994.02 79.03 52.85 Cash Conversion Cycle 73.33 62.97 47.13 26.12 2.17 354.36 112.97 49.24 Total Debt/Equity 0.16 0.19 0.23 1.35 3.79 4.47 5.36 6.95 Interest Cover 14.98 11.18 7.74 7.40 2.71 -4.03 1.25 1.38

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Book Value (Rs.)

58.71

46.93

38.02

60.11

21.79

10.57

181.60

159.00

ROA

9.54%

13.41%

18.58%

22.23%

9.77%

-2.44%

1.39%

2.48%

ROE

14.63%

21.00%

34.73%

103.22%

69.39%

-18.28%

12.74%

27.67%

ROCE

16.85%

18.42%

28.63%

48.91%

21.92%

-2.61%

8.64%

12.03%

Fixed Asset Turnover

2.14

3.10

3.47

4.12

5.19

0.25

1.30

2.93

Receivable days

106.84

99.89

90.07

65.35

31.00

255.82

90.87

46.82

Inventory Days

34.95

28.97

18.77

23.03

28.61

1092.56

101.13

55.27

Payable days

68.45

65.88

61.70

62.26

57.45

994.02

79.03

52.85

Cash Conversion Cycle

73.33

62.97

47.13

26.12

2.17

354.36

112.97

49.24

Total Debt/Equity

0.16

0.19

0.23

1.35

3.79

4.47

5.36

6.95

Interest Cover

14.98

11.18

7.74

7.40

2.71

-4.03

1.25

1.38

Description Mar 20 Mar 19 Mar 18
Book Value (Rs.) 59.41 47.31 38.02 ROA 9.82% 12.10% 13.64% ROE 19.21% 21.79% 20.57% ROCE 20.71% 18.41% 19.36% Fixed Asset Turnover 2.17 3.04 2.80 Receivable days 114.47 109.26 104.25 Inventory Days 43.97 34.14 20.24 Payable days 71.61 67.09 57.25 Cash Conversion Cycle 86.83 76.30 67.23 Total Debt/Equity 0.40 0.49 0.23 Interest Cover 5.63 6.52 7.74

Beta Drugs Ltd.

Pharmaceuticals & Drugs

BSE: Not Listed | NSE: BETA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update

Beta Drugs Ltd.

Pharmaceuticals & Drugs

BSE: Not Listed | NSE: BETA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update